Cytoreductive surgery and ovarian carcinoma

Acta Biomedica de l'Ateneo Parmense

Volumn 80, Issue 3, 2009, Pages 230-233

  Balbi, Giancarlo ^a   Monteverde, Antonietta ^a   Landino, Isabella ^a   Manganaro, Maria Amparo ^a   Franzese, Ciro ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cytoreductive surgery; Ovarian carcinoma; Overall survivalof improved survival rate after surgery

Indexed keywords

AGED; ARTICLE; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY CARCINOMA; OVERALL SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; OVARIECTOMY; OVARY TUMOR; POSTOPERATIVE COMPLICATION; TUMOR RECURRENCE;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; OVARIECTOMY; POSTOPERATIVE COMPLICATIONS;

EID: 77955895410     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Zang RY, Li ZT, Tang J, et al. Secondary cytoreductive surgery for patients with relapsed peithelial ovarian carcinoma: Who Benefits? Cancer 2004; 100: 1152-61.
2. Khalil El-Sayed A, Fakhr I, Younis A, El-Shahawy M, Adel I. Cytoreductive surgery for advanced epithelial tumors of the ovary: technical considerations and outcome. J Egypt Natl Canc Inst 2005; 17 (3): 158-64.
3. Fader AN, Rose PG. Role of surgery in ovarian carcinoma. J Clin Oncol 2007; 25 (20): 2873-83.
4. Schwartz PE. Cytoreductive surgery in the management of ovarian cancer. Oncology (Williston Park) 2008; 22(9): 1025-33; discussion 1033-8, 1041, 1045
5. Salani R, Santillan A, Zahurak L, et al. Secondary cytoreductive surgery for localized recurrent epithelial ovarian cancer. Cancer 2007; 109 (4): 685-91.
6. Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial avarian carcinoma. Cancer 2000; 88: 144-53.
7. Morris M, Gershenson DM, Wharton JT, Secondary cytoreductive surgery in epithelial ovarian cancer: non responders to first-line therapy. Ginecol Oncol 1989; 33: 1-5.
8. Mithel G, Zarca D, Castairgne D, Prade M. Secondary cytoreductive surgery in ovarian cancer. Eur J Surg Oncol 1989; 15: 201-4.
9. Axtell AE, Lee MH, Bristow RE, et al. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol 2007; 25: 384-9.
10. Bijelic L, Jonson A, Sugarbaker PH. Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol 2007; 18 (12): 1943-50.
11. Naik R, Nordin A, Cross PA, Hemming D, De Barros Lopes A, Monaghan JM. Optimal cytoreductive surgery is an independent prognostic indicator in stage VI epithelial ovarian cancer with hepatic metastases. Gynecol Oncol 2000, 78: 171-5.
12. Curtin JP, Malik R, Venkatraman ES, Barakat RR, Hoskins WJ. Stage VI ovarian cancer: Impact of surgical debulking. Gynecol Oncol 1997; 64: 9-12.
13. Berek JS, Hacker NF, Lagasse LD, Nieberg RK, Elashoff RM. Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol 1983; 61: 189-93.
14. Onda T, Yoshikawa H, Yasugi T, Yamada M, Matsumoto K, Taketani Y. Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection. Br J Cancer 2005; 92 (6): 1026-32.
15. Gadducci A, Iacconi P, Cosio S, Fanucchi A, Cristofani R, Genazzani AR. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecol Oncol 2000; 79: 344-9.
16. Zang RY, Zhang ZY, Li ZT, Chen J, Tang MQ, Liu Q, et al. Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer. J Surg Oncol 2000; 75: 24-30.
17. Eisenkop SM, Friedman RL, Spirtos NM. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 2000; 88: 144-53.
18. Eisenkop SM, Friedman RL,Wang HJ. Secondary cytoreductive surgery for recurrent ovarian cancer: a prospective study. Cancer 1995; 76: 1606-14.
19. Gronlund B, Lundvall L, Christensen IJ, Knudsen JB, Hogdall C. Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxelplatinum. Eur J Surg Oncol 2005; 31: 67-73.